FL H0111

Creates collaborative pharmacy practice agreements allowing pharmacists with a PharmD degree or 5 years of experience to initiate, modify, or discontinue drug therapy for chronic conditions (diabetes, hypertension, asthma, HIV/AIDS, etc.) under written agreements with physicians

Authorizes pharmacists to test, screen, and treat minor nonchronic conditions including influenza, streptococcus, lice, ringworm, and athlete's foot, with influenza and strep testing requiring a written protocol with a supervising physician

Requires pharmacists to complete a 20-hour initial training course and maintain $250,000 in professional liability insurance before practicing under these expanded authorities

Mandates ongoing continuing education of 8 hours biennially for collaborative practice agreements and 3 hours biennially for minor condition treatment, plus 5-year patient record retention

Prohibits pharmacists from initiating or prescribing controlled substances under these arrangements and requires written approval from pharmacy owners if practicing as an employee